Company / R&D per Share
Black Diamond Therapeutics, Inc. R&D per Share History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$21.55
FY2020
5-year range
$10.01 / $21.55
FY2019-FY2020
Trend
+115.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
21.55 in FY2020.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, r&d per share increased 115.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.60 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $21.55 | +115.4% |
| FY2019 | $10.01 | - |
As of FY2020 · SEC Form 10-K · Last checked Jun 21, 2026